Molecular Evolution of Peptide Ligands with Custom-Tailored Characteristics for Targeting of Glycostructures

PLoS Computational Biology

Volumn 8, Issue 12, 2012, Pages

  Röckendorf, Niels ^a   Borschbach, Markus ^b   Frey, Andreas ^a  

^a RESEARCH CENTER BORSTEL   (Germany)

^b UNIVERSITY OF APPLIED SCIENCES   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MEMBRANES; HEALTH; ITERATIVE METHODS; LIGANDS; MOLECULAR BIOLOGY; MOLECULES;

COMPUTER ASSISTED; CUSTOMIZABLE; GLYCOSTRUCTURES; IN-SILICO; IN-VITRO ASSAYS; MOLECULAR EVOLUTION; OPTIMIZATION STRATEGY; PEPTIDE LIGAND; TARGETING MOLECULES; THERAPEUTIC INTERVENTION;

PEPTIDES;

GANGLIOSIDE GM1;

ARTICLE; COMPUTER MODEL; CONTROLLED STUDY; EVOLUTIONARY ALGORITHM; FLUORESCENCE ANALYSIS; IN VITRO STUDY; MOLECULAR EVOLUTION; MUTATION RATE; PROCESS DEVELOPMENT; PROCESS OPTIMIZATION; PROTEIN DEGRADATION; PROTEIN STABILITY; SEQUENCE ANALYSIS; STRUCTURE ANALYSIS;

EID: 84872031595     PISSN: 1553734X     EISSN: 15537358     Source Type: Journal    
DOI: 10.1371/journal.pcbi.1002800     Document Type: Article

References (29)

1. Allen TM, (2002) Ligand-targeted therapeutics in anticancer therapy. Nat Rev Cancer 2: 750-763.
2. Olafsen TO, Wu AM, (2010) Antibody vectors for imaging. Semin Nucl Med 40: 167-181.
3. Wu AM, Senter PD, (2005) Arming antibodies: prospects and challenges for immunoconjugates. Nat Biotechnol 23: 1137-1146.
4. Sheridan C, (2007) Pharma consolidates its grip on post-antibody landscape. Nat Biotechnol 25: 365-366.
5. Audie J, Boyd C, (2010) The synergistic use of computation, chemistry and biology to discover novel peptide-based drugs: the time is right. Curr Pharm Design 5: 567-582.
6. Lee S, Xie J, Chen X, (2010) Peptide-based probes for targeted molecular imaging. Biochemistry 49: 1364-1376.
7. Fischer PM, (2003) The design, synthesis and application of stereochemical and directional peptide isomers: a critical review. Curr Prot Peptide Sci 4: 339-356.
8. Fonseca SB, Pereira MP, Kelley SO, (2009) Recent advances in the use of cell-penetrating peptides for medical and biological applications. Adv Drug Del Rev 61: 953-964.
9. Rubinstein M, Niv MY, (2009) Peptidic modulators of protein-protein interactions: progress and challenges in computational design. Biopolymers 91: 505-513.
10. Vanhee P, van der Sloot AM, Verschueren E, Serrano L, Rousseau F, et al. (2011) Computational design of peptide ligands. Trends Biotechnol 29: 231-239.
11. Yuan L, Kurek I, English J, Keenan R, (2005) Laboratory directed protein evolution. Mic Mol Biol Rev 69: 373-392.
12. Singh J, Ator MA, Jaeger EP, Allen MP, Whipple DA, et al. (1996) Application of genetic algorithms to combinatorial synthesis: a computational approach to lead identification and lead optimization. J Am Chem Soc 118: 1669-1676.
13. Schneider G, Schrödl W, Wallukat G, Müller J, Nissen E, et al. (1998) Peptide design by artificial neural networks and computer-based evolutionary search. Proc Natl Acad Sci U S A 95: 12179-12184.
14. Fjell CD, Hiss JA, Hancock REW, (2012) Designing antimicrobial peptides: form follows function. Nat Rev Drug Dis 11: 37-51.
15. Frey A, Giannasca KT, Weltzin R, Giannasca PJ, Reggio H, et al. (1996) Role of the glycocalyx in regulating access of microparticles to apical plasma membranes of intestinal epithelial cells: implications for microbial attachment and oral vaccine targeting. J Exp Med 184: 1045-1059.
16. Frank M, Schloissnig S, (2010) Bioinformatics and molecular modelling in glycobiology. Cell Mol Life Sci 67: 2749-2772.
17. Röckendorf N, Bade S, Hirst TR, Gorris H-H, Frey A, (2007) Synthesis of a fluorescent ganglioside GM1 derivative and screening of a synthetic peptide library for GM1 binding sequence motifs. Bioconjugate Chem 18: 573-578.
18. Frey A, Di Canzio J, Zurakowski D, (1998) A statistically defined endpoint titer determination method for immunoassays. J Immunol Methods 221: 35-41.
19. Back T, Fogel DB, Michalewicz Z (1992) Handbook of evolutionary computation. London; New York: Taylor & Francis. 988 p.
20. Yokobayashi Y, Ikebukuro K, McNiven S, Karube I, (1996) Directed evolution of trypsin inhibiting peptides using a genetic algorithm. J Chem Soc, Perkin Trans 1 20: 2435-2437.
21. Knapp B, Giczi V, Ribarics R, Schreiner W, (2011) PeptX: Using genetic algorithms to optimize peptides for MHC binding. BMC Bioinformatics 12: 241-249.
22. Hohm T, Limbourg P, Hoffmann D, (2006) A multiobjective evolutionary method for the design of peptidic mimotopes. J Comput Biol 13: 113-125.
23. Borschbach M, (2005) Neural classification of biological properties and genetic operator configuration issues. Trans Information Sci Appl 2 (12):: 2235-2242.
24. Zhang W, Yano K, Karube I, (2007) Improving the efficiency of evolutionary de novo peptide design: strategies for probing configuration and parameter settings. BioSystems 88: 35-55.
25. Pielou EC, (1966) Measurement of diversity in different types of biological collections. J Theoret Biol 13: 131-144.
26. Matsubara T, Iijama K, Nakamura M, Taki T, Okahata Y, et al. (2007) Specific binding of GM1-binding peptides to high-density GM1 in lipid membranes. Langmuir 23: 708-714.
27. Gorris HH, Bade S, Röckendorf N, Albers E, Schmidt MA, et al. (2009) Rapid profiling of peptide stability in proteolytic environments. Anal Chem 81: 1580-1586.
28. Frank R, (1992) Spot synthesis: an easy technique for the positionally addressable, parallel chemical synthesis on a membrane support. Tetrahedron 48: 9217-9232.
29. Ast T, Heine N, Germeroth L, Schneider-Mergener J, (1999) Efficient assembly of peptomers on continuous surfaces. Tetrahedron Lett 40: 4317-4318.